Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
Danuta M. Skowronski, Samantha E Kaweski, Michael A. Irvine, et al.
Canadian Medical Association Journal (2022) Vol. 194, Iss. 47, pp. E1599-E1609
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 348-357
Open Access | Times Cited: 145
Learning to Fake It: Limited Responses and Fabricated References Provided by ChatGPT for Medical Questions
Jocelyn Gravel, Madeleine D’Amours-Gravel, Esli Osmanlliu
Mayo Clinic Proceedings Digital Health (2023) Vol. 1, Iss. 3, pp. 226-234
Open Access | Times Cited: 91
Respiratory syncytial virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational study
Marina Viñeta Paramo, Lilian P.L. Ngo, Bahaa Abu-Raya, et al.
The Lancet Regional Health - Americas (2023) Vol. 25, pp. 100582-100582
Open Access | Times Cited: 37
The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023
Tanya Murphy, Hanna Swail, Jaspreet Jain, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 31, pp. E1030-E1037
Open Access | Times Cited: 29
Learning to fake it: limited responses and fabricated references provided by ChatGPT for medical questions
Jocelyn Gravel, Madeleine D’Amours-Gravel, Esli Osmanlliu
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 22
The role of vaccine status homophily in the COVID-19 pandemic: a cross-sectional survey with modelling
Elisha B. Are, Kiffer G. Card, Caroline Colijn
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Pediatric COVID-19 severity by SARS-CoV-2 lineage and vaccine status in Canada: an IMPACT study
Daniel S. Farrar, Julie A. Bettinger, Aaron Campigotto, et al.
Pediatric Research (2025)
Closed Access
Risk of SARS-CoV-2 infection before and after the Omicron wave in a cohort of healthcare workers in Ontario, Canada
Jorge Martínez-Cajas, Ann Jolly, Yanping Gong, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Changes in emergency department use in British Columbia, Canada, during the first 3 years of the COVID-19 pandemic
Jiayun Yao, Michael A. Irvine, Braeden Klaver, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 34, pp. E1141-E1150
Open Access | Times Cited: 14
Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada
Sara Carazo, Danuta M. Skowronski, Marc Brisson, et al.
The Lancet Healthy Longevity (2023) Vol. 4, Iss. 8, pp. e409-e420
Open Access | Times Cited: 13
Comparison of influenza and COVID-19 hospitalisations in British Columbia, Canada: a population-based study
Solmaz Setayeshgar, James Wilton, Hind Sbihi, et al.
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e001567-e001567
Open Access | Times Cited: 12
Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, et al.
AIDS (2022) Vol. 37, Iss. 5, pp. 709-721
Open Access | Times Cited: 18
Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic
Zhencui Li, Pei Hu, Qu Lin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
A Novel Anti-nucleocapsid Antibody Avidity Method for Identifying SARS-CoV-2 Reinfections
Liam Golding, Allison W. Watts, Jacob Shew, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e579-e583
Open Access | Times Cited: 2
Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination
Sharon Walmsley, Majid Nabipoor, Freda Qi, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 564-564
Open Access | Times Cited: 2
Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022
Irina Kislaya, Aryse Martins Melo, Marta Barreto, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 3, pp. 590-594
Open Access | Times Cited: 7
SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada
Allison W. Watts, Louise C. Mâsse, David A. Goldfarb, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e071228-e071228
Open Access | Times Cited: 7
Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022
Simon Galmiche, Tiffany Charmet, Arthur Rakover, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2334084-e2334084
Open Access | Times Cited: 7
COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series
Sharon Walmsley, Leah Szadkowski, Bradly G. Wouters, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106506-106506
Open Access | Times Cited: 6
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada
Danuta M. Skowronski, Samantha E Kaweski, Michael A. Irvine, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 42, pp. E1427-E1439
Open Access | Times Cited: 6
Seroprevalence of Anti-SARS-CoV-2 Antibodies Following the Omicron BA.1 Wave
Maja Sočan, Katarina Prosenc, Maja Mrzel
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3665-3665
Open Access | Times Cited: 5
COVID-19 Vaccine Uptake in Immigrant, Refugee, and Nonimmigrant Children and Adolescents in Ontario, Canada
Julia Brandenberger, Raquel Duchen, Hong Lu, et al.
JAMA Network Open (2023) Vol. 6, Iss. 7, pp. e2325636-e2325636
Open Access | Times Cited: 5
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study
Alessia Raineri, Thomas Radtke, Sonja Rueegg, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults
Sarah L. Silverberg, Hennady P. Shulha, Brynn McMillan, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022
Amy Y. X. Yu, Peter C. Austin, Cynthia A. Jackevicius, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top